AbbVie signs $10 bln deal to buy cancer drugmaker ImmunoGen, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Through the deal, AbbVie gains Elahere that is approved for ovarian cancer patients who have received previous therapies, and is also being tested in earlier lines of treatment., Through the deal, AbbVie gains Elahere that is approved for ovarian cancer patients who have received previous therapies, and is also being tested in earlier lines of treatment., , Read More